+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Vietnam Healthcare Logistics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2027-2032)

  • PDF Icon

    Report

  • 150 Pages
  • October 2026
  • Region: Vietnam
  • Mordor Intelligence
  • ID: 6294121
The Vietnam healthcare logistics market size is valued at USD 2.04 billion in 2026. It is estimated to grow from USD 2.21 billion in 2027 to reach USD 3.23 billion by 2032, at a CAGR of 7.91% during the forecast period (2027-2032). This report is Segmented by Logistics (Transportation, Warehousing and Distribution, and More), by Temperature (Temperature, Non-Temperature), by Product (Pharmaceuticals, Vaccines, and More), by Destination (Domestic, International), by End User (Pharmaceutical Manufacturers, and More), and by Region (Northern, Central, Southern Vietnam). The Market Forecasts are Provided in Terms of Value (USD).

Vietnam Healthcare Logistics Market Trends and Insights

Temperature-Sensitive Therapies Increasing Specialized Logistics Demand

The Vietnam healthcare logistics market is seeing demand for more specialized handling as biologics, vaccines, and advanced therapies require product-specific storage and transport conditions. Some cell and gene therapy products require cryogenic temperatures of −150 °C or below, supported by suitable containers, monitoring, and chain-of-custody procedures. Other products require different temperature ranges, so requirements must be determined by the product and its validated shipping system. These needs increase the importance of qualified packaging, trained personnel, and documented handling procedures. In October 2025, LOGISTEED Vietnam received IATA CEIV Pharma certification at Tan Son Nhat International Airport, becoming the first freight forwarder in Vietnam to obtain the certification. The certification supports pharmaceutical air cargo quality management and strengthens the country's specialist handling capability at a major international gateway.

Healthcare Investment Expanding Pharmaceutical Distribution Requirements

Healthcare investment supports demand for the movement and storage of medicines, medical devices, diagnostic products, and hospital supplies. In 2026, the National Assembly approved an investment policy for the 2026-2030 phase of the National Target Program on Healthcare, Population, and Development, with planned funding of VND 88.635 trillion (USD 3.55 billion). Greater healthcare activity can increase demand for inbound transport, compliant storage, inventory management, and distribution to hospitals and other healthcare outlets. Expanding access to healthcare could also create a need for more reliable distribution networks connecting major supply hubs with underserved areas.

Validated Cold-Chain Operations Increasing Logistics Costs

Cold-chain operations generally cost more than ambient warehousing and transportation because they require suitable equipment, temperature monitoring, documented procedures, trained staff, and ongoing quality management. Providers may also need to maintain backup systems, calibrate monitoring devices, and preserve records that demonstrate compliance during storage and transport. These requirements can increase the cost of handling vaccines, biologics, and other temperature-sensitive products. Providers serving smaller customers or routes with low shipment density may find it more difficult to spread these costs across sufficient volume. Certified facilities and specialist vehicles are therefore more commercially viable where demand is concentrated around major healthcare centres, airports, pharmaceutical customers, and distribution hubs. Providers need to balance investment in validated infrastructure with the expected volume and service requirements of their customers.

Other drivers and restraints analyzed in the detailed report include:

  1. Logistics Outsourcing Increasing Specialist Provider Adoption
  2. Regulatory Requirements Shaping Specialist Logistics Participation
  3. Rural Infrastructure Gaps Raising Temperature-Excursion Risks

Segment Analysis

Transportation accounts for 49.16% of the Vietnam healthcare logistics market share in 2026, reflecting the importance of moving medicines, medical devices, diagnostic products, and hospital supplies between import gateways, warehouses, manufacturers, wholesalers, hospitals, and pharmacies. Road transport supports regular domestic distribution, while air freight is important for time-sensitive imports and specialist healthcare shipments. Sea freight also supports international movements of products suitable for longer transit times. The operating requirements differ by product category, and temperature-sensitive shipments may need qualified packaging, monitoring, and documented handovers. Reliable transport networks are therefore essential to maintaining product availability across the country's geographically dispersed healthcare system.

Value-added services and others are projected to register at a CAGR of 9.89% through 2032, the fastest rate in the logistics-function segmentation. These services can include inventory management, temperature-excursion reporting, returns handling, traceability support, and other customer-specific activities. Pharmaceutical companies may use these services to strengthen product visibility and reduce the internal resources needed to manage distribution. The ability to combine transportation and storage with quality documentation and inventory information can improve service coordination. Providers must ensure that these services meet customer requirements and applicable regulations, particularly when handling products that require additional controls.

Temperature-controlled logistics accounts for 55.92% of the Vietnam healthcare logistics market size in 2026 and is projected to register at a CAGR of 8.45% through 2032. The segment serves products that require specified storage and transport conditions, including certain vaccines, biologics, specialty medicines, and injectables. The appropriate range depends on the product label and validated distribution requirements. Some products require refrigerated conditions, while others need frozen or ultra-low-temperature handling. Providers need to align storage equipment, packaging, transport schedules, and monitoring processes with each product's requirements. Demand for these services supports investment in qualified facilities and specialist vehicles, although the cost of maintaining controlled conditions can be higher than for ambient distribution.

Non-temperature-controlled logistics remains important for products that can be stored and transported under ambient conditions, including many medical consumables, devices, and standard medicines. These flows form a broad base of healthcare distribution activity and still require appropriate storage, traceability, and handling. Temperature-controlled operations add equipment and monitoring costs, creating a higher operating threshold for providers entering the specialist segment. The market's projected growth indicates increasing demand for controlled handling. Still, providers must continue to serve ambient products efficiently because these remain an important part of the overall healthcare supply chain.

Complete Report Scope:

  • By Logistics Function
    • Transportation
      • Road
      • Air
      • Sea and Inland Waterways
      • Rail
    • Warehousing and Distribution
    • Value-added Services and Others
  • By Temperature Type
    • Temperature Controlled
      • Chilled (0-5 °C)
      • Frozen (-20-0 °C)
      • Ambient
      • Deep-Frozen / Ultra-Low (less than-20 °C)
    • Non-Temperature Controlled
  • By Product Type
    • Pharmaceuticals
      • Prescription and Specialty Drugs
      • OTC Drugs
    • Biopharmaceuticals (Biologics and Biosimilars)
    • Vaccines
    • Clinical Trial Materials
    • Cell and Gene Therapies
    • Medical Devices
    • Veterinary Medicine
    • Blood, Plasma and Blood Components
    • Diagnostic and Laboratory Products
    • Organs and Human Tissues
    • Others
  • By Destination
    • Domestics
    • International
  • By End User
    • Pharmaceutical Manufacturers
    • Biopharmaceutical Manufacturers
    • Hospitals and Clinics
    • Hospitals and Retail Pharmacies
    • Healthcare Distributors and Wholesalers
    • Others
  • By Region
    • Northern Vietnam
    • Central Vietnam
    • Southern Vietnam

List of Companies Covered in this Report:

  1. DHL Group
  2. United Parcel Service (UPS)
  3. Kuehne+Nagel
  4. DSV
  5. CEVA Logistics
  6. FedEx Corporation
  7. Yusen Logistics
  8. Nippon Express Holdings
  9. CJ Logistics
  10. A.P. Moller - Maersk
  11. Zuellig Pharma
  12. DKSH Holding
  13. Indo Trans Logistics Corporation (ITL)
  14. Transimex Corporation
  15. LOGISTEED Group
  16. ABA Cooltrans
  17. GONSA
  18. Sapharco
  19. FM Logistic
  20. Konoike Group
  21. Nichirei Logistics Group
  22. LOTTE Global Logistics

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
3.1 Market Size, Growth, and Forecast Outlook
3.2 Key Demand Drivers and Healthcare Logistics Trends
3.3 Major Distribution Hubs and Demand Concentration
3.4 Competitive Landscape and Leading Healthcare Logistics Providers
4 MARKET LANDSCAPE
4.1 Market Overview and Role of Logistics in Healthcare
4.2 Healthcare Spending Trends
4.3 Market Drivers
4.3.1 Temperature-Sensitive Therapies Increasing Specialized Logistics Demand
4.3.2 Healthcare Investment Expanding Pharmaceutical Distribution Requirements
4.3.3 Logistics Outsourcing Increasing Specialist Provider Adoption
4.3.4 Regulatory Opening Supporting Foreign Logistics Participation
4.3.5 Digital Monitoring Strengthening GDP Compliance and Visibility
4.3.6 Remote Healthcare Access Expanding Specialized Distribution Networks
4.4 Market Restraints
4.4.1 Validated Cold-Chain Operations Increasing Logistics Costs
4.4.2 Rural Infrastructure Gaps Raising Temperature-Excursion Risks
4.4.3 Skilled Talent Shortages Constraining Healthcare Logistics Expansion
4.4.4 Fragmented Qualification Standards Increasing Provider Compliance Complexity
4.5 Regulatory Framework for Healthcare Logistics Operations
4.6 Healthcare Supply Chain and Distribution Network Analysis
4.7 Technology Innovation and Digital Logistics Outlook
4.8 Evolution of Healthcare Logistics Requirements
4.9 Pharmaceutical Distribution Network and Cargo Flow Analysis
4.10 Cold Chain Capacity and Infrastructure Development Analysis
4.11 Healthcare Warehousing and Distribution Hub Network Analysis
4.12 Porter's Five Forces Analysis
4.12.1 Threat of New Entrants
4.12.2 Bargaining Power of Suppliers
4.12.3 Bargaining Power of Buyers
4.12.4 Threat of Substitutes
4.12.5 Rivalry Among Competitors
4.13 Impact of Geo-Political Events on Supply Chain Shifts
5 MARKET SIZE AND GROWTH FORECASTS
5.1 By Logistics Function
5.1.1 Transportation
5.1.1.1 Road
5.1.1.2 Air
5.1.1.3 Sea and Inland Waterways
5.1.1.4 Rail
5.1.2 Warehousing and Distribution
5.1.3 Value-added Services and Others
5.2 By Temperature Type
5.2.1 Temperature Controlled
5.2.1.1 Chilled (0-5 °C)
5.2.1.2 Frozen (-20-0 °C)
5.2.1.3 Ambient
5.2.1.4 Deep-Frozen / Ultra-Low (less than-20 °C)
5.2.2 Non-Temperature Controlled
5.3 By Product Type
5.3.1 Pharmaceuticals
5.3.1.1 Prescription and Specialty Drugs
5.3.1.2 OTC Drugs
5.3.2 Biopharmaceuticals (Biologics and Biosimilars)
5.3.3 Vaccines
5.3.4 Clinical Trial Materials
5.3.5 Cell and Gene Therapies
5.3.6 Medical Devices
5.3.7 Veterinary Medicine
5.3.8 Blood, Plasma and Blood Components
5.3.9 Diagnostic and Laboratory Products
5.3.10 Organs and Human Tissues
5.3.11 Others
5.4 By Destination
5.4.1 Domestics
5.4.2 International
5.5 By End User
5.5.1 Pharmaceutical Manufacturers
5.5.2 Biopharmaceutical Manufacturers
5.5.3 Hospitals and Clinics
5.5.4 Hospitals and Retail Pharmacies
5.5.5 Healthcare Distributors and Wholesalers
5.5.6 Others
5.6 By Region
5.6.1 Northern Vietnam
5.6.2 Central Vietnam
5.6.3 Southern Vietnam
6 COMPETITIVE LANDSCAPE
6.1 Market Concentration
6.2 Key Strategic Moves
6.3 Market Share Analysis
6.4 Company Profiles (includes Global Level Overview, Market Level Overview, Core Segments, Financials as available, Strategic Information, Geographic Coverage, Products and Services, Recent Developments)
6.4.1 DHL Group
6.4.2 United Parcel Service (UPS)
6.4.3 Kuehne+Nagel
6.4.4 DSV
6.4.5 CEVA Logistics
6.4.6 FedEx Corporation
6.4.7 Yusen Logistics
6.4.8 Nippon Express Holdings
6.4.9 CJ Logistics
6.4.10 A.P. Moller - Maersk
6.4.11 Zuellig Pharma
6.4.12 DKSH Holding
6.4.13 Indo Trans Logistics Corporation (ITL)
6.4.14 Transimex Corporation
6.4.15 LOGISTEED Group
6.4.16 ABA Cooltrans
6.4.17 GONSA
6.4.18 Sapharco
6.4.19 FM Logistic
6.4.20 Konoike Group
6.4.21 Nichirei Logistics Group
6.4.22 LOTTE Global Logistics
7 MARKET OPPORTUNITIES AND FUTURE OUTLOOK
7.1 White-Space Opportunities and Unmet Healthcare Logistics Needs
7.2 High-Potential Healthcare Segments and Growth Opportunities
7.3 Strategic Growth Priorities Across Healthcare Logistics Ecosystem
7.4 Future Market Outlook and Emerging Healthcare Demand Pockets

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • DHL Group
  • United Parcel Service (UPS)
  • Kuehne+Nagel
  • DSV
  • CEVA Logistics
  • FedEx Corporation
  • Yusen Logistics
  • Nippon Express Holdings
  • CJ Logistics
  • A.P. Moller - Maersk
  • Zuellig Pharma
  • DKSH Holding
  • Indo Trans Logistics Corporation (ITL)
  • Transimex Corporation
  • LOGISTEED Group
  • ABA Cooltrans
  • GONSA
  • Sapharco
  • FM Logistic
  • Konoike Group
  • Nichirei Logistics Group
  • LOTTE Global Logistics